These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19414344)

  • 1. Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
    Moe BT; Vereide AB; Orbo A; Jaeger R; Sager G
    Anticancer Res; 2009 Apr; 29(4):1047-52. PubMed ID: 19414344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis.
    Moe BG; Vereide AB; Orbo A; Sager G
    Anticancer Res; 2009 Apr; 29(4):1053-8. PubMed ID: 19414345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines.
    Navo MA; Smith JA; Gaikwad A; Burke T; Brown J; Ramondetta LM
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):483-9. PubMed ID: 18004570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early effects of high concentrations of progesterone and mifepristone A gene expression study of endometrial cancer cells (Ishikawa).
    Ørbo A; Moe BT; Grønaas H; Paulssen RH
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):139-49. PubMed ID: 19138738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S; Chen X; Lu X; Yu Y; Feng Y
    Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
    Okada H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of progesterone, levonorgestrel and medroxyprogesterone acetate on apoptosis in human endometrial endothelial cells.
    Choksuchat C; Zhao S; Deutch TD; Kimble TD; Archer DF
    Contraception; 2009 Feb; 79(2):139-45. PubMed ID: 19135572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
    Vereide AB; Kaino T; Sager G; Arnes M; Ørbo A
    Gynecol Oncol; 2006 May; 101(2):214-23. PubMed ID: 16325240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.
    Meng CX; Andersson KL; Bentin-Ley U; Gemzell-Danielsson K; Lalitkumar PG
    Fertil Steril; 2009 Jan; 91(1):256-64. PubMed ID: 18206148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
    Seeger H; Wallwiener D; Mueck AO
    Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone.
    Paulssen RH; Moe B; Grønaas H; Orbo A
    Steroids; 2008 Jan; 73(1):116-28. PubMed ID: 18037150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth inhibition by progestins in human endometrial cancer cells with progesterone receptors].
    Tanizawa O; Terakawa N
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):917-23. PubMed ID: 3389835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone.
    Mirkin S; Archer DF
    Contraception; 2004 Oct; 70(4):327-33. PubMed ID: 15451338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells.
    Li A; Felix JC; Minoo P; Amezcua CA; Jain JK
    Fertil Steril; 2005 Jul; 84(1):202-11. PubMed ID: 16009178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer.
    Fujimoto J; Fujita H; Hosoda S; Okada H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1836-40. PubMed ID: 2531782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.
    Hanekamp EE; Kühne LM; Grootegoed JA; Burger CW; Blok LJ
    Endocr Relat Cancer; 2004 Dec; 11(4):831-41. PubMed ID: 15613456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.
    Smid-Koopman E; Blok LJ; Kühne LC; Burger CW; Helmerhorst TJ; Brinkmann AO; Huikeshoven FJ
    J Soc Gynecol Investig; 2003 Jan; 10(1):49-57. PubMed ID: 12517594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486.
    Tseng L; Mazella J; Sun B
    Endocrinology; 1986 Apr; 118(4):1312-8. PubMed ID: 2936597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer.
    Hanekamp EE; Gielen SC; Smid-Koopman E; Kühne LC; de Ruiter PE; Chadha-Ajwani S; Brinkmann AO; Grootegoed JA; Burger CW; Huikeshoven FJ; Blok LJ
    Clin Cancer Res; 2003 Sep; 9(11):4190-9. PubMed ID: 14519645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.